 Prospective trial interferon-alpha children chronic hepatitis Thirty-six children chronic hepatitis controlled trial recombinant human interferon-alpha patients hepatitis virus DNA levels aminotransferases serum Twelve children MU interferon-alpha body surface area times week group children conditions group II children controls group III mo therapy patients group group II hepatitis virus DNA serum negative Comparison rate response group controls significant difference Eleven patients hepatitis virus DNA serum HBeAg anti-HBe improvement liver histological findings loss hepatitis virus DNA liver serum ALT levels normal Interferon-alpha children therapy findings course interferon-alpha effective serological biochemical histological remission disease children chronic hepatitis